MKSI vs REGN · P/E 93, rev $2.33B vs P/E 14, rev $4.29B
MKS Instruments Inc (MKSI) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
MKS Instruments Inc (MKSI) is a scientific & technical instruments company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MKSI revenue for 2026-06-30 was $2.33B. Net income was $258.0M. MKSI currently screens at market cap $30.04B and trailing P/E 93.4.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MKSI currently screens at market cap $30.04B and trailing P/E 93.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MKSI and REGN stock pages for the full models.
Not investment advice.